Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Withdrawn 1 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 22 Colonic Neoplasms 12 Rectal Neoplasms 11 Carcinoma, Hepatocellular 10 Stomach Neoplasms 7 Digestive System Neoplasms 3 Neurotoxicity Syndromes 2 Neoplasms 2 Neoplasm Metastasis 2 Intestinal Neoplasms 2 Gastrointestinal Neoplasms 2 Gastrointestinal Diseases 2 Cholangiocarcinoma 2 Recurrence 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Neoadjuvant Therapy 1 Liver Neoplasms 1 Intestinal Diseases 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1 Advanced Colorectal Cancer 1

Interventions

Gemcitabine 78 Fluorouracil 27 Oxaliplatin 24 130-nm albumin-bound paclitaxel 24 Leucovorin 18 Capecitabine 15 Albumin-Bound Paclitaxel 15 S 1 (combination) 14 Taxes 12 Irinotecan 11 pembrolizumab 9 folfirinox 9 Radiosurgery 9 Radiotherapy 7 Drug Therapy 7 Cisplatin 7 irinotecan sucrosofate 6 Pancreaticoduodenectomy 5 Paclitaxel 5 Injections 5 Docetaxel 5 Blood Specimen Collection 5 apatinib 4 Radiofrequency Ablation 4 Radiation 4 Biopsy 4 tislelizumab 3 rubitecan 3 nimotuzumab 3 camrelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Folfox protocol × Clear all

NCT03666832 2022-06-15

MP-PDAC-01

Samsung Medical Center

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡